Association of the reduced levels of monocyte chemoattractant protein-1 with herpes zoster in rheumatoid arthritis patients treated with janus kinase inhibitors in a single-center cohort

HIGHLIGHTS

• What: Given the elevated risks of herpes zoster (HZ) in rheumatoid arthritis (RA) patients treated with (JAKis) the authors aimed to examine the relationship between autoantibodies with HZ development in JAKi-treated patients. This study received approval from the Institutional Review Board of Chinese Medicine 3 of 10 University Hospital (CMUH110-REC1-086), and informed consent was obtained from each participant in accordance with the Declaration of Helsinki.
• Who: Po-Ku Chen and collaborators from the Rheumatology and Immunology Center, China Medical University Hospital, Taichung, Taiwan have published the research: Association of the Reduced Levels . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.